Stock comparison
JOHNSON & JOHNSON is 85.9x more valuable than Alkermes plc. by market capitalization ($655.15 B vs $7.63 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
JNJ is larger
JOHNSON & JOHNSON is 85.9x more valuable than Alkermes plc. by market capitalization ($655.15 B vs $7.63 B).
Market value leader
JNJ
JOHNSON & JOHNSON is 85.9x more valuable than Alkermes plc. by market capitalization ($655.15 B vs $7.63 B).
Revenue leader
JNJ
ALKS: $1.48B vs JNJ: $94.19B.
Profit leader
JNJ
ALKS: $241.70M vs JNJ: $26.80B.
Margin leader
JNJ
ALKS: 16.4% vs JNJ: 28.5% net margin.
| Metric | ALKS | JNJ |
|---|---|---|
| Market cap | $7.63 B | $655.15 B |
| US-listed rank | #1079 | #17 |
| Revenue (latest FY) | $1.48B | $94.19B |
| Net income (latest FY) | $241.70M | $26.80B |
| Net margin | 16.4% | 28.5% |
| P/E (trailing FY) | 31.6x | 24.4x |
| SEC filings | 1,882 | 1,004 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
JOHNSON & JOHNSON is 85.9x more valuable than Alkermes plc. by market capitalization ($655.15 B vs $7.63 B).
In their latest fiscal years, Alkermes plc. reported $1.48B in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: Alkermes plc. and JOHNSON & JOHNSON, or browse the full rankings.